Diagnostic Imaging Vol 31 No 2

As an experienced journalist but a neophyte to radiology, I went to Chicago with a healthy mixture of curiosity and trepidation. I had prepared for the RSNA sessions I was assigned to cover but wondered if the megatechnical presentations would be over my head.

Two years ago, my 70-yearoldfather-in-law decided his3500-square-foot house wastoo big and his household neededto downsize.

Studies examining the clinical historiesof patients who developednephrogenic systemic fibrosis aftertreatment at distinguished teachinghospitals in New York City andVienna suggest that gadoliniumbasedcontrast dose and post-MRIhemodialysis are keys to controllingthe rare but deadly skin disorder

I read with interest your article on nephrogenic systemic fibrosis and the “heavy collateraldamage” that radiologists face due to the off-label uses of gadoliniumagents and subsequent development of NSF in somepatients

X-ray, the past and current workhorse in radiology,still garners the majority of all imagingstudies.

Researchers were stunned when preliminary results of an ongoing study showed that patients who undergo vertebroplasty may die sooner than patients with vertebral fractures who do not undergo the procedure.

Despite encouraging earlier results, themuch-awaited follow-up phase III DIAS-2trial on ischemic stroke patients treated withdesmoteplase afterthe onset of symptomsdid not showany improvement inclinical response at90 days.

An incidental finding of multiple sclerosistypelesions during brain MRI is no fluke. Anew study has found that some patientsdevelop the physical symptoms of the diseasewithin five years of the abnormalities'discovery on MRI.

University of California, San Diego scientists are developing a new imaging modality that will study the body/brain dynamics of humans engaged in normal activity.

Diagnostic imaging utilization rates don’t just swing wildly across the 10 Medicare regions.

Conventional radiography/fluoroscopyhas always been cumbersome.